MetLife Investment Advisors »

Halozyme Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 140k 36.96
2023-09-30 $5.4M 141k 38.20
2023-06-30 $5.3M 147k 36.07
2023-03-31 $5.7M 150k 38.19
2022-12-31 $8.7M 152k 56.90
2022-09-30 $6.2M 158k 39.54
2022-06-30 $6.9M 157k 44.00
2022-03-31 $6.5M 162k 39.88
2021-12-31 $4.7M 116k 40.21
2021-09-30 $4.8M 119k 40.68
2021-06-30 $5.3M 117k 45.41
2021-03-31 $4.8M 116k 41.69
2020-12-31 $5.2M 123k 42.71
2020-09-30 $1.6M 60k 26.27
2020-06-30 $1.6M 60k 26.81
2020-03-31 $1.0M 57k 17.99
2019-12-31 $1.1M 65k 17.74
2019-09-30 $1.0M 65k 15.51
2019-06-30 $1.1M 65k 17.18
2019-03-31 $897k 56k 16.10
2018-12-31 $815k 56k 14.62
2018-09-30 $1.6M 88k 18.17
2018-06-30 $940k 56k 16.87
2018-03-31 $1.1M 56k 19.59
2017-12-31 $1.1M 56k 20.26